Key Takeaway
Your patient rights when using compounded medications are real, specific, and enforceable. This patient rights compounded medications resource covers the essential information you need to make informed decisions.
Your patient rights when using compounded medications are real, specific, and enforceable. This patient rights compounded medications resource covers the essential information you need to make informed decisions. If you are receiving compounded semaglutide for weight management or a peptide like BPC-157 for healing, you have the right to safe medication, transparent information, and recourse if something goes wrong. Many patients do not know these rights exist.
Key Takeaways: - Your Right to Know What Is in Your Medication - Your Right to a Licensed Provider and Pharmacy - Your Right to Informed Consent - Your Right to Report Problems - Your Right to Continuity of Care
Here is everything you are entitled to as a patient.
Your Right to Know What Is in Your Medication
You have the right to know exactly what is in the vial you are injecting. This includes the active ingredient, its concentration, the inactive ingredients (such as bacteriostatic water or preservatives), the beyond-use date, and the lot number.
Every compounded medication should come with a label that includes the patient's name, the medication name and strength, the pharmacy name and contact information, the prescribing provider's name, the beyond-use date, storage instructions, and the lot or batch number.
If your medication arrives without a proper label, contact the pharmacy immediately. You should not use unlabeled or poorly labeled injectable medications. A complete label is not a courtesy. It is a legal requirement.
Beyond the label, you have the right to request a certificate of analysis (COA) for your specific batch. A COA documents the results of quality testing performed on the medication, including potency, sterility, and endotoxin testing. A pharmacy that refuses to provide a COA upon request is not operating at the quality level you deserve.
"We now have cardiovascular outcomes data showing semaglutide reduces MACE events by 20% in people with obesity, independent of diabetes status. The SELECT trial changed how we think about these medications.") Dr. A. Michael Lincoff, MD, Cleveland Clinic, lead author of SELECT
For more on evaluating your medication source, see our guide on .
Your Right to a Licensed Provider and Pharmacy
You have the right to receive your compounded medication only through a licensed provider and a licensed pharmacy. Both should be verifiable through public databases.
Your prescribing provider must hold an active, unrestricted medical license in the state where you reside. You can verify this through your state's medical board website. The provider must evaluate your health before prescribing and must be available for follow-up questions and care adjustments.
Free Download: Compounding Pharmacy Verification Checklist A complete guide to verifying your provider's license, your pharmacy's credentials, and your medication's quality. Get yours free (we'll email it to you instantly.
[Download CTA Button]
Your pharmacy must hold an active license from its state board of pharmacy. If the pharmacy is in a different state than you, it should also hold a nonresident pharmacy permit in your state (requirements vary by state). You can verify pharmacy licenses through state board websites.
You have the right to contact your pharmacy directly. A legitimate pharmacy has a phone number staffed by licensed pharmacists who can answer your questions. If you cannot reach your pharmacy directly, that is a problem.
You also have the right to choose a different provider or pharmacy at any time. You are not locked into any single provider or pharmacy relationship. If you are unsatisfied with your care, your medication quality, or the customer service you receive, you can switch.
Your Right to Informed Consent
Before starting any compounded medication, you have the right to informed consent. This means your provider must explain what the medication is and how it works, the expected benefits and the evidence supporting them, the potential risks and side effects, the alternatives to this treatment, and the fact that the medication is compounded and not FDA-approved as a finished product.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for physician-supervised GLP-1 therapy.
Try the BMI Calculator →This last point is important. Your provider should clearly explain that compounded medications contain the same active ingredient as brand-name products but are not FDA-approved finished products. You should understand this distinction before starting treatment.
Informed consent is not just a form you sign. It is a conversation. You should feel comfortable asking questions and receiving clear, honest answers. If a provider rushes through consent or seems annoyed by your questions, consider finding a different provider.
About the is part of informed consent. Your provider should discuss the most common side effects and what to do if you experience them.
Your Right to Report Problems
If something goes wrong with your compounded medication, you have multiple reporting options.
Report to your provider. This is always the first step. Your provider can evaluate your symptoms, adjust your treatment, and document the event in your medical record.
Report to the pharmacy. The pharmacy needs to know about quality problems so they can investigate and correct them. This includes issues like medication that looks different than expected, labeling errors, or adverse reactions that may be related to medication quality.
Report to the FDA. The MedWatch program accepts reports from patients about adverse events, medication quality problems, and medication errors. You can file online at the FDA's website or by calling 1-800-FDA-1088. Your report helps the FDA identify safety signals that may affect other patients.
Report to your state board of pharmacy. If you believe the pharmacy made a compounding error, failed to follow proper procedures, or provided substandard medication, your state board has the authority to investigate and take enforcement action.
Report to your state medical board. If your provider prescribed inappropriately, failed to evaluate you properly, or did not provide informed consent, your state medical board can investigate.
You also have the right to legal recourse if you are harmed by a defective compounded medication. Consulting with a healthcare attorney can help you understand your options if you have suffered a significant adverse event.
Your Right to Continuity of Care
You have the right to continuity in your treatment. This means your provider should not abruptly discontinue your medication without a transition plan. If your current medication becomes unavailable due to regulatory changes, your provider should discuss alternatives and help you transition.
You should receive adequate notice before any change to your medication source, formulation, or pricing. Surprise changes that affect your treatment are unacceptable. A responsible provider communicates proactively.
You have the right to refills in a timely manner. Running out of medication due to pharmacy or provider delays should not happen with proper planning. If you are on a monthly prescription, your refill process should start well before your current supply runs out.
You also have the right to your medical records. If you switch providers, your previous provider must transfer your records upon request. This ensures your new provider has full context on your treatment history.
FormBlends is designed to provide with proactive refill management and provider availability for questions between scheduled visits.
Frequently Asked Questions
Do I have the right to see the testing results for my compounded medication?
Yes. You have the right to request a certificate of analysis (COA) for any batch of compounded medication you receive. The COA documents potency, sterility, and endotoxin testing results. A legitimate pharmacy provides this documentation upon request.
Can I switch compounding pharmacies if I am unhappy with the quality?
Yes. You are not obligated to continue using any specific pharmacy. Talk to your provider about switching to a different pharmacy. Your prescription can be transferred or your provider can write a new prescription for a different pharmacy.
What if my provider refuses to answer my questions about my compounded medication?
You have the right to clear, honest answers about your treatment. If your provider is unwilling to discuss the details of your compounded medication, including its source, quality standards, and the differences from brand-name products, consider finding a provider who values transparency.
Are my rights different for compounded medications versus brand-name medications?
Your fundamental patient rights are the same regardless of whether your medication is compounded or brand-name. You have the right to safe medication, informed consent, transparent information, and recourse if problems arise. The main difference is that compounded medications have different regulatory oversight, which makes asking questions about quality and sourcing even more important.
Your Personalized Plan Is Waiting
No two patients are the same, and your protocol shouldn't be either. FormBlends providers create customized treatment plans based on your health profile, goals, and preferences.
Sources & References
- Centers for Disease Control and Prevention. Multistate Outbreak of Fungal Meningitis and Other Infections) United States, 2012. MMWR. 2012;61(41):839-842.
- U.S. Food and Drug Administration. Drug Quality and Security Act (DQSA). Public Law 113-54. November 27, 2013.
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. Doi:10.1056/NEJMoa2032183
- Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2 (Davies et al., Lancet, 2021)). Lancet. 2021;397(10278):971-984. Doi:10.1016/S0140-6736(21)00213-0
- Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3 (Wadden et al., JAMA, 2021)). JAMA. 2021;325(14):1403-1413. Doi:10.1001/jama.2021.1831
- Garvey WT, Batterham RL, Bhatt DL, et al. Two-Year Effects of Semaglutide in Adults with Overweight or Obesity (STEP 5 (Garvey et al., Nat Med, 2022)). Nat Med. 2022;28:2083-2091. Doi:10.1038/s41591-022-02026-4
- Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. Doi:10.1056/NEJMoa2307563
Nothing in this article should be construed as medical advice. The information provided is educational only. Always consult with your healthcare provider before beginning, modifying, or discontinuing any medication or treatment. FormBlends connects patients with licensed providers for individualized care.
Last updated: 2026-03-24